Determination of the distribution volume that can be used to calculate the intravenous loading dose

Clinical Pharmacokinetics

Volumn 35, Issue 1, 1998, Pages 1-7

  Wada, D Russell ^a   Drover, David R ^a   Lemmens, Harry J M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL; MORPHINE;

DISTRIBUTION VOLUME; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; PRIORITY JOURNAL; REVIEW;

ALFENTANIL; FENTANYL; HUMANS; INFUSIONS, INTRAVENOUS; MORPHINE;

EID: 0031871911     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199835010-00001     Document Type: Review

References (26)

1. Schüttler J, Schwilden H, Stoeckel H. Pharmacokinetics as applied to total intravenous anaesthesia. Anaesthesia 1983; 38S: 53-6
2. Barratt RL, Graham GG, Torda TA. Kinetics of thiopentone in relation to the site of sampling. Br J Anaesth 1984; 56: 1385-90
3. Helmers H, Van Peer A, Woestenborghs R, et al. Alfentanil kinetics in the elderly. Clin Pharmacol Ther 1984; 36: 239-43
4. Lemmens HJM, Bovill JG, Burm AGL, et al. Alfentanil infusion in the elderly, prolonged computer infusion of alfentanil in the elderly surgical patient. Anaesthesia 1988; 43: 850-6
5. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics: I. Clin Pharmacokinet 1989; 17: 175-99
6. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics: II. Clin Pharmacokinet 1989; 17: 275-90
7. DiStefano JJ. Optimized blood sampling protocols and sequential design of kinetic experiments. Am J Physiol 1981; 240: R259-6 5
8. Ducharme J, Varin F, Bevan DR, et al. Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clin Pharmacokinet 1993; 24: 507-18
9. Raemer DB, Buschman A, Varvel JR, et al. The prospective use of population pharmacokinetics in a computer driven infusion system for alfentanil. Anesthesiology 1990; 73: 66-72
10. Shafer SL, Varvel JR, Aziz N, et al. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990; 73: 1091-102
11. Barvais L, Cantraine F, D'Hollander A, et al. Predictive accuracy of continuous alfentanil infusion in volunteers: variability of different pharmacokinetic sets. Anesth Analg 1993; 77: 801-10
12. Coetzee JF, Glen JB, Wium CA, et al. Pharmacokinetic model selection for target controlled infusions of propofol: assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45
13. Vaughan DP, Tucker GT. General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration: theoretical application to lignocaine. Eur J Clin Pharmacol 1976; 10: 433-7
14. Chiou WL. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination. J Pharmacokinet Biopharm 1979; 7: 527-36
15. Roerig DL, Kotrly KJ, Dawson CA, et al. First-past uptake of verapamil, diazepam, and thiopental in the human lung. Anesth Analg 1989; 69: 461-6
16. Taeger K, Weninger E, Schmelzer F, et al. Pulmonary kinetics of fentanyl and alfentanil in surgical patients. Br J Anaesth 1988; 61: 425-34
17. Niazi S. Volume of distribution as a function of time. J Pharm Sci 1976; 65: 452-4
18. Shafer SL, Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm 1992; 20: 147-69
19. Henthorn TK, Krejcie TC, Shanks CA, et al. Time-dependent distribution volume and kinetics of the pharmacodynamic effector site. J Pharm Sci 1992; 81: 1136-8
20. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24-33
21. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23
22. Murphy MR, Hug CC. Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide. Anesthesiology 1981; 54: 187-92
23. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159-66
24. Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modeling to analgesia. In: Foley KM, Inturrisi CE, editors. Advances in pain research and therapy: opioid analgesics in the management of clinical pain. New York: Raven Press, 1986: 441-52
25. Rosow C. Pharmacology of opioid analgetic agents. In: Rogers MC, Tinker JH, Covino BG, et al., editors. Principles and practice of anesthesiology. St Louis: Moshy Year Book, 1993: 1155-83
26. Hill HF, Chapman CR, Saeger LS, et al. Steady-state infusions of opioids in human. II. Concentration-effect relationships and therapeutic margins. Pain 1990; 43: 69-79